» Articles » PMID: 37108456

An Efficient 2D Protocol for Differentiation of IPSCs into Mature Postmitotic Dopaminergic Neurons: Application for Modeling Parkinson's Disease

Abstract

About 15% of patients with parkinsonism have a hereditary form of Parkinson's disease (PD). Studies on the early stages of PD pathogenesis are challenging due to the lack of relevant models. The most promising ones are models based on dopaminergic neurons (DAns) differentiated from induced pluripotent stem cells (iPSCs) of patients with hereditary forms of PD. This work describes a highly efficient 2D protocol for obtaining DAns from iPSCs. The protocol is rather simple, comparable in efficiency with previously published protocols, and does not require viral vectors. The resulting neurons have a similar transcriptome profile to previously published data for neurons, and have a high level of maturity marker expression. The proportion of sensitive (SOX6+) DAns in the population calculated from the level of gene expression is higher than resistant (CALB+) DAns. Electrophysiological studies of the DAns confirmed their voltage sensitivity and showed that a mutation in the gene is associated with enhanced store-operated calcium entry. The study of high-purity DAns differentiated from the iPSCs of patients with hereditary PD using this differentiation protocol will allow for investigators to combine various research methods, from patch clamp to omics technologies, and maximize information about cell function in normal and pathological conditions.

Citing Articles

STIM Proteins: The Gas and Brake of Calcium Entry in Neurons.

Skobeleva K, Wang G, Kaznacheyeva E Neurosci Bull. 2024; 41(2):305-325.

PMID: 39266936 PMC: 11794855. DOI: 10.1007/s12264-024-01272-5.


GQIcombi application to subdue glioma via differentiation therapy.

Kolesnikova V, Revishchin A, Fab L, Alekseeva A, Ryabova A, Pronin I Front Oncol. 2024; 14:1322795.

PMID: 38988707 PMC: 11233813. DOI: 10.3389/fonc.2024.1322795.


SinCMat: A single-cell-based method for predicting functional maturation transcription factors.

Barvaux S, Okawa S, Sol A Stem Cell Reports. 2024; 19(2):270-284.

PMID: 38215756 PMC: 10874865. DOI: 10.1016/j.stemcr.2023.12.006.

References
1.
Drouin-Ouellet J, Barker R . Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything?. Stem Cells Int. 2013; 2012:926147. PMC: 3539381. DOI: 10.1155/2012/926147. View

2.
Shafa M, Yang F, Fellner T, Rao M, Ahmadian Baghbaderani B . Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. Front Med (Lausanne). 2018; 5:69. PMC: 5862873. DOI: 10.3389/fmed.2018.00069. View

3.
Cobb M, Ravisankar A, Skibinski G, Finkbeiner S . iPS cells in the study of PD molecular pathogenesis. Cell Tissue Res. 2017; 373(1):61-77. PMC: 5997490. DOI: 10.1007/s00441-017-2749-y. View

4.
Bogomiakova M, Sekretova E, Eremeev A, Shuvalova L, Bobrovsky P, Zerkalenkova E . Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing. Stem Cell Res. 2021; 55:102451. DOI: 10.1016/j.scr.2021.102451. View

5.
Patro R, Duggal G, Love M, Irizarry R, Kingsford C . Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017; 14(4):417-419. PMC: 5600148. DOI: 10.1038/nmeth.4197. View